July 27, 2026 3-5pm ET

Monday on The Robert Scott Bell Show:





Hour 1

BREAKING–Dr. Anthony Fauci’s Post-Vaccination Pulmonary Embolism and the Disconnect in Public Health Policy Documents released by Senator Rand Paul reveal that in June 2021 Dr. Anthony Fauci suffered an acute pulmonary infarct resulting from a pulmonary embolism, a known side effect of mRNA COVID-19 vaccination, just months after receiving his primary Moderna series, and was prescribed anticoagulation therapy with Eliquis. On December 22, 2020, Fauci had publicly received his first dose of the Moderna mRNA-1273 vaccine at the NIH Clinical Center as a highly visible demonstration of confidence in the shots. Despite this personal health crisis, he continued to advocate for universal vaccination and policies that pressured the public to accept the same interventions. Fauci later contracted SARS-CoV-2 in June 2022 while fully vaccinated and twice-boosted. Author Peter A. McCullough, MD, MPH, argues that the episode exposes a profound dissonance between the official narrative of universal vaccine safety and the private medical realities faced by those directing the policy, noting that Fauci either knew or should have known the risks of vaccine-associated vascular events yet kept his own experience private while encouraging others to take the same product. The piece frames the revelation as a significant breach of public trust and a case study in the gap between public directives and personal experience among pandemic response leaders.

Large NYC study adds evidence linking glyphosate to preterm birth risk Pregnant women with higher exposure to glyphosate, the active ingredient in the weedkiller Roundup, faced a significantly higher risk of spontaneous preterm labor before 37 weeks, according to one of the largest studies to date examining the link in humans. Led by NYU Langone Health and published in Environmental Pollution, the research analyzed urine samples from 1,450 women who gave birth between 2016 and 2019 at New York City hospitals and found that those with higher mid-pregnancy glyphosate levels were more likely to go into spontaneous labor early compared to those with lower levels. Preterm birth is a leading cause of newborn illness and death and can lead to infections as well as long-term learning and developmental challenges. Participants lived far from agricultural fields, indicating exposure likely came from food. Senior author Dr. Leonardo Trasande noted that the findings support the need for individual and societal changes in diet and food production to protect pregnant women and infants. Epidemiologist Jessie Buckley of the University of North Carolina at Chapel Hill emphasized that even modest associations matter because pregnancy is a sensitive window and that glyphosate exposure is a systems-level problem requiring policy decisions rather than relying solely on individual choices such as organic food. A Ruveon (Bayer) spokesperson stated that the study reports statistical associations but does not establish causation and that limited sampling could have led to exposure misclassification. The study follows a Supreme Court ruling limiting pesticide liability lawsuits and a Trump administration executive order protecting glyphosate production.

1 in 3 People Living With Allergies — What’s to Blame? Around one in three people in many Western countries now live with an allergic condition such as asthma, eczema, hay fever or food allergy, with U.S. figures showing roughly 31.8 percent of adults and 27.2 percent of children affected and the U.K. among the highest rates in Europe and the world. Genetics alone cannot explain the rapid rise because human genes have changed little while allergies have become one of the four most common chronic diseases globally. Growing evidence links the increase to modern changes in diet, gut health, environmental exposures and reduced microbial diversity, including widespread antibiotic use in early life, air pollution, ultraprocessed foods high in refined sugars and additives that disrupt the gut microbiome, and limited childhood exposure to soil and diverse microbes. Approximately 70 to 80 percent of immune cells reside in the gastrointestinal tract, where the system learns immune tolerance, and Western diets low in fiber and high in processed foods appear to impair that training process. Studies such as the COCOA birth cohort found higher maternal intake of baked and sugary processed foods associated with increased childhood food allergies, while higher dietary fiber intake has been linked to lower overall mortality. Current medical approaches focus largely on symptom management with antihistamines, inhalers and immunotherapies that improve quality of life and can be lifesaving but do not restore underlying immune balance. The article argues that reversing the allergy epidemic requires addressing root causes through dietary and environmental changes rather than relying solely on long-term disease management, noting that the global food allergy market is projected to grow substantially as the healthcare model remains centered on symptom control.

Sweat, Death, and the 95% Your Blood Test Cannot See Finnish men who used a sauna four to seven times a week had a 37 percent lower all-cause mortality rate, a 63 percent lower rate of sudden cardiac death, and a 50 percent lower rate of fatal cardiovascular disease compared with those who used it once a week, according to the Kuopio Ischaemic Heart Disease Risk Factor Study of 2,315 middle-aged men followed for a median of 20.7 years, with the associations holding after adjustment for blood pressure, cholesterol, smoking, physical activity, and cardiorespiratory fitness. Longer sessions also reduced risk, and later analyses showed reduced dementia and Alzheimer’s risk. A separate NHANES-III analysis found low-level blood lead exposure linked to an estimated 412,000 U.S. deaths annually, with no safe threshold, yet more than 95 percent of adult lead burden is stored in bone with a half-life of decades rather than the roughly one month measured by blood tests. Estimating bone lead roughly doubled the cardiovascular mortality hazard ratios. Research by Genuis and others shows that many toxic elements, including lead, BPA, phthalates, and certain pesticides, appear preferentially in sweat and are sometimes undetectable in blood or urine, indicating standard blood panels underestimate total body burden. Exercise-induced sweat contained roughly eleven times more lead and nickel than passive sauna sweat at matched rates, while mercury did not increase under either condition due to its sequestration in red blood cells. The article argues that frequent sweating may remove stored toxins that blood tests miss and that this detoxification pathway contributes to the observed mortality benefits beyond cardiovascular conditioning alone.

Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
Today’s Homeopathic Hit is Kousso, also known as Hagenia abyssinica or Brayera.
Boericke highlights this remedy as a vermifuge, especially in relation to tapeworm, with nausea, vomiting, vertigo, praecordial anxiety, slowed and irregular pulse, subdelirium, collapse, and rapid extreme prostration.

Download the  Information Sheet


Hour 2

Pharma Looks to Cash in on Psychedelics as Patients Seek Alternatives to Psychotropic Drugs for Depression Eli Lilly’s approximately $2.8 billion acquisition of AtaiBeckley, with up to $1 billion in additional milestone payments, marks the largest pharmaceutical investment yet in psychedelic medicine and gives the company control of experimental therapies including BPL-003, a fast-acting nasal spray containing N,N-dimethyltryptamine being studied for treatment-resistant depression that received FDA Breakthrough Therapy designation. The deal follows AbbVie’s 2025 agreement to acquire Gilgamesh Pharmaceuticals’ experimental depression treatment Bretisilocin for up to $1.2 billion, signaling major drugmakers’ growing interest in psychedelic compounds as a potential new category of mental health treatments for patients who have not responded adequately or have been harmed by existing medications. Experts note that companies cannot typically patent naturally occurring psychedelics in their original forms and instead seek intellectual property protections for modified compounds, delivery systems, manufacturing methods and specific medical uses, creating proprietary products such as engineered nasal sprays and buccal films. Concerns include whether corporate development will preserve therapy-assisted models that shaped psychedelic research or shift toward shorter-duration compounds designed to fit existing healthcare systems, potentially removing the substances from their natural and cultural contexts. The Multidisciplinary Association for Psychedelic Studies expressed both recognition of pharmaceutical validation of the research and worry that therapy could be left behind in favor of the compounds alone. Pharmaceutical investment is expected to stimulate discussion of insurance coverage and healthcare infrastructure while raising questions about patents, profits, access and the future character of psychedelic therapy.

UK government scraps plans for digital ID cards after millions of Brits opposed The United Kingdom’s incoming prime minister Andy Burnham has confirmed that the government is scrapping a controversial digital ID card scheme announced last year by former prime minister Keir Starmer, with the savings to be used for a tax cut aimed at reducing household electricity bills amid rising living costs. Newly appointed finance minister John Healy said the changes aim to provide breathing room on bills and reassurance this winter. Starmer had argued that state-issued digital IDs would crack down on migrants working illegally and modernize access to government services, with the national system projected to cost £1.8 billion over three years, though that figure was disputed because funding was allegedly never allocated. Starmer announced his intention to resign on June 22 and was formally replaced by Burnham on Monday. Millions of Britons opposed the mandatory digital ID cards, generating the second-largest public parliamentary petition on record with close to 3 million signatures, as critics warned the system would enable surveillance. The plan revived memories of a similar identity card program under the Tony Blair government in the 2000s that was axed in 2011 after a new opposition-led coalition took power following a national election.

Here Are 3 AI Companies Betting They Can Replace Doctors While most clinical AI tools aim to assist physicians by reducing documentation or supporting decisions, a smaller group of startups is developing systems intended to replace doctors for routine care. Doctronic, a New York-based company that has raised $65 million, operates a free 24/7 HIPAA-compliant AI doctor platform and is authorized in Utah to renew prescriptions for chronic conditions without human approval under a regulatory sandbox agreement, approving 72 percent of renewals independently for 192 drugs with independent physician agreement of 91 percent in those cases and no reported serious safety incidents so far. Certuma, founded by Martin Varsavsky and backed by $10 million in seed funding at a $60 million valuation, is pursuing FDA approval as an autonomous AI doctor for 25 low-risk high-frequency conditions such as UTIs, strep throat and sinusitis while already offering diagnosis and prescribing advice via chatbot in Argentina, with longer-term plans for robotic booths. Ada Health, a Berlin-based firm that has raised $242 million and reports 13 million users completing more than 32 million symptom assessments, functions as an AI health companion that triages symptoms and often routes patients away from physician visits. These efforts contrast with major AI companies and health systems that focus on copilots to free doctors for complex judgment, though some systems have already cut support staff roles. Regulatory pathways remain fragmented, with Utah’s non-enforcement agreement enabling limited AI prescribing while many other states require licensed human clinicians for final medical decisions and bar nonhuman entities from clinical titles. The companies argue AI can handle routine cases to improve access, while critics note that medicine involves more than pattern matching and that accountability and safety questions remain unresolved.

Stuffed toys can release short-chain PFAS into saliva, study finds A recent study has found that stuffed toys can release short-chain per- and polyfluoroalkyl substances (PFAS) into children’s saliva when mouthed or chewed, raising concerns about potential exposure to these “forever chemicals” through everyday play. Researchers tested a range of common plush toys and detected short-chain PFAS compounds that migrate more readily than longer-chain variants, with higher release observed under conditions simulating sucking or biting. Short-chain PFAS are increasingly used as replacements for longer-chain chemicals that have been restricted, yet they remain persistent in the environment and the human body and have been linked in other research to potential health effects including hormone disruption and immune impacts. The findings suggest that young children, who frequently put toys in their mouths, may face additional routes of PFAS exposure beyond food packaging, water, and household products. Experts recommend choosing toys certified free of fluorinated chemicals where possible, washing new stuffed animals before use, and limiting prolonged mouthing of soft toys, while calling for greater transparency and regulation of PFAS in children’s products. The study adds to growing evidence of widespread PFAS contamination in consumer goods and the challenges of fully eliminating exposure in daily life.

Paul Andrews, Founder of the Woodstock of U.F.O.s, Dies at 77 Paul Andrews, an entrepreneur who founded Contact in the Desert, an annual U.F.O. convention known as the Woodstock of U.F.O.s, died on June 30 at his home in Walnut Creek, California, at age 77. His death was confirmed by his wife, Abigail Lewis, without a specified cause. A lifelong believer in the paranormal after childhood experiences of luminous beings visiting his sister, Andrews launched Contact in the Desert in 2013 at the Joshua Tree Retreat Center in Southern California, drawing thousands for lectures on contact experiences, crop circles, government cover-ups, interstellar science and night-vision skywatching. Tickets cost around $250 and featured speakers including astronauts, scientists and U.F.O. reporters such as Art Bell, George Noory and Linda Moulton Howe. Earlier, in the late 1980s, he ran the Whole Life Expo, a traveling New Age trade show featuring crystals, meditation aids, speakers like Timothy Leary and Uri Geller, and his own accounts of a near-death experience. Andrews partnered with Victoria GeVoian to create Contact in the Desert as a safe space for people to discuss unconventional experiences. Born November 15, 1948, in Elizabeth, New Jersey, he studied at Fairleigh Dickinson University, worked with figures in consciousness research, and sold meditation and stimulation devices after moving to California in 1976. He is survived by his wife, their daughter Caitlyn Valle and two grandchildren. Contact in the Desert was sold to new owners in 2023.



Remember Friends, The Power to Heal is Yours!



What would you like to hear from The Robert Scott Bell Show? Call us at 1-866-939-BELL (2355) and let your voice be heard!

Previous episodes of the Robert Scott Bell Show: SoundCloud

Learn the best ways to keep your family fed when the trucks have stopped, the stores shut down, and no food is available. Go to http://RSBFood.com